Skip to main content
. 2017 Mar;23(3-b Suppl):10.18553/jmcp.2017.23.3-b.s17. doi: 10.18553/jmcp.2017.23.3-b.s17

TABLE 3.

Internal Validation: Comparison of Weibull Distribution-Predicted Outcomes with Clinical Trial Outcomes (Pirfenidone) and Registry Data (BSC)

Overall Survival Pirfenidone BSC
Weibull Distribution Prediction Observed Data Weibull Distribution Prediction Observed Data (Clinical Trial) Observed Data (Inova Registry)
52 weeks 96 97 93 93 90
72 weeks 93 94 87 91 84

Note: All values expressed in percentages.

BSC = best supportive care.